financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Carlyle Group to Invest $1.3 Billion in Trucordia
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Carlyle Group to Invest $1.3 Billion in Trucordia
Jun 4, 2025 5:04 AM

07:51 AM EDT, 06/04/2025 (MT Newswires) -- Carlyle Group's ( CG ) Global Credit platform plans to invest $1.3 billion in insurance brokerage Trucordia, the latter said on Wednesday.

The transaction is expected to close in June and values Trucordia at $5.7 billion, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
-- O3 Mining Brief: National Bank Thesis
-- O3 Mining Brief: National Bank Thesis "Heightened Given recent proposed integration in the district"
Aug 14, 2024
09:51 AM EDT, 08/14/2024 (MT Newswires) -- Price: 1.08, Change: -0.08, Percent Change: -6.90 ...
 -- O3 Mining Brief: National Bank Thesis based on prospective exploration upside in a Tier 1 jurisdiction, with M&A appeal given Marban's Near 2.6 mln oz in an operating mining jurisdiction
-- O3 Mining Brief: National Bank Thesis based on prospective exploration upside in a Tier 1 jurisdiction, with M&A appeal given Marban's Near 2.6 mln oz in an operating mining jurisdiction
Aug 14, 2024
09:50 AM EDT, 08/14/2024 (MT Newswires) -- Price: 1.08, Change: -0.08, Percent Change: -6.90 ...
 Why Is Dermatology-Focused Verrica Pharmaceuticals Stock Trading Lower On Wednesday?
Why Is Dermatology-Focused Verrica Pharmaceuticals Stock Trading Lower On Wednesday?
Aug 14, 2024
On Wednesday, dermatology drug developer Verrica Pharmaceuticals Inc. ( VRCA ) released preliminary results from Part 2 of its Phase 2 trial of VP-315 for basal cell carcinoma. The Phase 2 trial is a 2-part, open-label, multicenter, dose-escalation, proof-of-concept study with a safety run-in designed to assess the safety and tolerability, pharmacokinetics, and efficacy of VP-315 when administered intratumorally to...
 DexCom's Glucose Monitoring System Available for Insurance Coverage in Quebec
DexCom's Glucose Monitoring System Available for Insurance Coverage in Quebec
Aug 14, 2024
09:50 AM EDT, 08/14/2024 (MT Newswires) -- DexCom ( DXCM ) said Wednesday that its Dexcom G7 Continuous Glucose Monitoring System will be added to the Regie de l'assurance maladie du Quebec's Public Prescription Drug Insurance Plan. As a result, eligible type 1 diabetes patients will be able to receive coverage for Dexcom G7, the company said. Shares of DexCom...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved